Literature DB >> 1551903

Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells.

S Fazio1, Z Yao, B J McCarthy, S C Rall.   

Abstract

The synthesis and secretion of apolipoprotein (apo) E, a major protein component of very low density lipoproteins, were examined in the human hepatoma cell line HepG2 under metabolic conditions known to stimulate lipogenesis and the production of apoB-containing lipoproteins. When HepG2 cells were incubated in the presence of fetal bovine serum (5 or 10%) or canine chylomicron remnants (5 or 10 micrograms of protein), the secretion of triglycerides and cholesteryl esters of lipoproteins of d less than 1.063 g/ml increased, as determined by the incorporation of [14C]acetate. Determination of the distribution of apoE among media lipoproteins by agarose column chromatography showed that the majority of secreted apoE was associated with large lipoproteins when cells were incubated with fetal bovine serum. However, immunoblot analysis of total media apoE revealed that incubating cells with or without the lipogenic factors had no effect on the amount of apoE secreted. Pulse-chase and continuous labeling experiments demonstrated that the synthesis and secretion of apoE did not vary under the different metabolic conditions, even though there was a 5-fold increase in apoB secretion in response to increased lipogenesis. Neither apoE nor apoB mRNA levels responded to the lipogenic stimuli. We conclude that the synthesis and secretion of apoE are independent of the production of apoB-containing lipoproteins in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551903

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.

Authors:  F Kuipers; M C Jong; Y Lin; M Eck; R Havinga; V Bloks; H J Verkade; M H Hofker; H Moshage; T J Berkel; R J Vonk; L M Havekes
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

2.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

3.  Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

Authors:  M F Linton; R V Farese; G Chiesa; D S Grass; P Chin; R E Hammer; H H Hobbs; S G Young
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

4.  Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E.

Authors:  S Fazio; Y L Lee; Z S Ji; S C Rall
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Level of macrophage uPA expression is an important determinant of atherosclerotic lesion growth in Apoe-/- mice.

Authors:  Ranjini Krishnan; Michal Kremen; Jie Hong Hu; Isaac Emery; Stephen D Farris; Katherine I Slezicki; Talyn Chu; Liang Du; Helén L Dichek; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-03       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.